All Stories

  1. 24th international Biometals webinars
  2. Molecular Insights into Bismuth’s New Applications against Antimicrobial Resistance and Coronaviruses
  3. The metallome and the biological periodic table: A metal atlas in cells
  4. Au(I)-based compounds inhibit nsp14/nsp10 and nsp13 (helicase) to exert anti-SARS-CoV-2 properties
  5. Metal-modulated T cell antitumor immunity and emerging metalloimmunotherapy
  6. Metal-Based Approaches for the Fight against Antimicrobial Resistance: Mechanisms, Opportunities, and Challenges
  7. Hinokitiol potentiates antimicrobial activity of bismuth drugs: a combination therapy for overcoming antimicrobial resistance
  8. Bismuth drug eradicates multi-drug resistant Burkholderia cepacia complex via aerobic respiration
  9. Unprecedented allosteric inhibition of E. coli malate dehydrogenase by silver(i) from atomic resolution analysis
  10. Lighting Up and Identifying Metal-Binding Proteins in Cells
  11. Bismuth-based drugs sensitize Pseudomonas aeruginosa to multiple antibiotics by disrupting iron homeostasis
  12. Integration of metalloproteome and immunoproteome reveals a tight link of iron-related proteins with COVID-19 pathogenesis and immunity
  13. Protein-templated ligand discovery via the selection of DNA-encoded dynamic libraries
  14. Copper regulates the host innate immune response against bacterial infection via activation of ALPK1 kinase
  15. Clinically used drug arsenic trioxide targets XIAP and overcomes apoptosis resistance in an organoid-based preclinical cancer model
  16. Mechanistic insights into bismuth(iii) inhibition of SARS-CoV-2 helicase
  17. Metal-detection based techniques and their applications in metallobiology
  18. Introduction to “Chemical biology of metals”
  19. Development of Pan-Anti-SARS-CoV-2 Agents through Allosteric Inhibition of nsp14/nsp10 Complex
  20. SaeR as a novel target for antivirulence therapy against Staphylococcus aureus
  21. Metallo-sideromycin as a dual functional complex for combating antimicrobial resistance
  22. Metalloproteomics
  23. Mitochondrial ATP synthase as a direct molecular target of chromium(III) to ameliorate hyperglycaemia stress
  24. Rapid synthesis of bismuth-organic frameworks as selective antimicrobial materials against microbial biofilms
  25. Gold drugs as colistin adjuvants in the fight against MCR-1 producing bacteria
  26. A dual covalent binder for labelling and inhibiting serine and metallo-carbapenemases
  27. Dual-action gallium-flavonoid compounds for combating Pseudomonas aeruginosa infection
  28. Metallomics and metalloproteomics
  29. Metal-coding assisted serological multi-omics profiling deciphers the role of selenium in COVID-19 immunity
  30. Metal Complexes as Resistance Breakers or Metalloantibiotics for Combating Antimicrobial Resistance
  31. Computed Tomography of Cartilage: An Exploration of Novel Cationic Bismuth Contrast Agent
  32. Binding of ruthenium and osmium at non‑iron sites of transferrin accounts for their iron-independent cellular uptake
  33. An ensemble 3D deep-learning model to predict protein metal-binding site
  34. Metalloproteomics for Biomedical Research: Methodology and Applications
  35. Re-sensitization of mcr carrying multidrug resistant bacteria to colistin by silver
  36. Regulation of DNA-binding activity of the Staphylococcus aureus catabolite control protein A by copper (II)-mediated oxidation
  37. A hydroxide lock for metallo-β-lactamases
  38. Orally administered bismuth drug together with N-acetyl cysteine as a broad-spectrum anti-coronavirus cocktail therapy
  39. Multiplex metal-detection based assay (MMDA) for COVID-19 diagnosis and identification of disease severity biomarkers
  40. Metal-based strategies for the fight against COVID-19
  41. Multiplex Single‐Cell Analysis of Cancer Cells Enables Unbiased Uncovering Subsets Associated with Cancer Relapse: Heterogeneity of Multidrug Resistance in Precursor B‐ALL
  42. Eradication of Porphyromonas gingivalis Persisters Through Colloidal Bismuth Subcitrate Synergistically Combined With Metronidazole
  43. Author Correction: Multi-target mode of action of silver against Staphylococcus aureus endows it with capability to combat antibiotic resistance
  44. Multi-target mode of action of silver against Staphylococcus aureus endows it with capability to combat antibiotic resistance
  45. Clofazimine broadly inhibits coronaviruses including SARS-CoV-2
  46. Medicinal chemistry and biomedical applications of bismuth-based compounds and nanoparticles
  47. A. Sigel, E. Freisinger & R. K. O. Sigel (Eds.), M. E. Sosa Torres & P. M. H. Kroneck (volume Eds.): Transition Metals and Sulfur – A Strong Relationship for Life
  48. Resensitizing carbapenem- and colistin-resistant bacteria to antibiotics using auranofin
  49. Metallodrug ranitidine bismuth citrate suppresses SARS-CoV-2 replication and relieves virus-associated pneumonia in Syrian hamsters
  50. Metalloproteomics in conjunction with other omics for uncovering the mechanism of action of metallodrugs: Mechanism-driven new therapy development
  51. Bismuth—The Magic Element
  52. Atomic differentiation of silver binding preference in protein targets:Escherichia colimalate dehydrogenase as a paradigm
  53. Bismuth drugs as antimicrobial agents
  54. Predicting disease-associated mutation of metal-binding sites in proteins using a deep learning approach
  55. Zinc excess increases cellular demand for iron and decreases tolerance to copper in Escherichia coli
  56. Recognition of Proteins by Metal Chelation-Based Fluorescent Probes in Cells
  57. Metalloproteomics for Unveiling the Mechanism of Action of Metallodrugs
  58. Deciphering molecular mechanism of silver by integrated omic approaches enables enhancing its antimicrobial efficacy in E. coli
  59. Bismuth drugs tackle Porphyromonas gingivalis and attune cytokine response in human cells
  60. The unique trimeric assembly of the virulence factor HtrA from Helicobacter pylori occurs via N-terminal domain swapping
  61. A Novel Synthetic Compound, Bismuth Zinc Citrate, Could Potentially Reduce Cisplatin-Induced Toxicity Without Compromising the Anticancer Effect Through Enhanced Expression of Antioxidant Protein
  62. Green Fluorescent Probe for Imaging His6-Tagged Proteins Inside Living Cells
  63. MetaMarker: a pipeline for de novo discovery of novel metagenomic biomarkers
  64. Antimicrobial silver targets glyceraldehyde-3-phosphate dehydrogenase in glycolysis of E. coli
  65. Bismuth: Environmental Pollution and Health Effects
  66. Combination of gallium(iii) with acetate for combating antibiotic resistant Pseudomonas aeruginosa
  67. S-Dimethylarsino-glutathione (darinaparsin®) targets histone H3.3, leading to TRAIL-induced apoptosis in leukemia cells
  68. Systems Approaches for Unveiling the Mechanism of Action of Bismuth Drugs: New Medicinal Applications beyond Helicobacter Pylori Infection
  69. Cell Cycle-Dependent Uptake and Cytotoxicity of Arsenic-Based Drugs in Single Leukemia Cells
  70. The role of citrate, lactate and transferrin in determining titanium release from surgical devices into human serum
  71. Bismuth antimicrobial drugs serve as broad-spectrum metallo-β-lactamase inhibitors
  72. Metallochaperone UreG serves as a new target for design of urease inhibitor: A novel strategy for development of antimicrobials
  73. Multi-omics and temporal dynamics profiling reveal disruption of central metabolism inHelicobacter pylorion bismuth treatment
  74. Tracking iron-associated proteomes in pathogens by a fluorescence approach
  75. Functional disruption of peroxiredoxin by bismuth antiulcer drugs attenuates Helicobacter pylori survival
  76. A Ni-NTA-based red fluorescence probe for protein labelling in live cells
  77. Cytotoxicity of arsenic trioxide in single leukemia cells by time-resolved ICP-MS together with lanthanide tags
  78. Identification of catabolite control protein A fromStaphylococcus aureusas a target of silver ions
  79. Integration of fluorescence imaging with proteomics enables visualization and identification of metallo-proteomes in living cells
  80. Integrative approach for the analysis of the proteome-wide response to bismuth drugs in Helicobacter pylori
  81. Exploration into the nickel ‘microcosmos’ in prokaryotes
  82. UreE-UreG Complex Facilitates Nickel Transfer and Preactivates GTPase of UreG in Helicobacter pylori
  83. Glutathione and multidrug resistance protein transporter mediate a self-propelled disposal of bismuth in human cells
  84. Rapid labeling of intracellular His-tagged proteins in living cells
  85. Loss of APD1 in Yeast Confers Hydroxyurea Sensitivity Suppressed by Yap1p Transcription Factor
  86. Metallomic and metalloproteomic strategies in elucidating the molecular mechanisms of metallodrugs
  87. “Anion clamp” allows flexible protein to impose coordination geometry on metal ions
  88. On-line coupling of continuous-flow gel electrophoresis with inductively coupled plasma-mass spectrometry to quantitatively evaluate intracellular metal binding properties of metallochaperones HpHypA and HpHspA in E. coli cells
  89. Bio-coordination of bismuth in Helicobacter pylori revealed by immobilized metal affinity chromatography
  90. Selective interaction of Hpn-like protein with nickel, zinc and bismuth in vitro and in cells by FRET
  91. Antimony and Bismuth
  92. Structure of RPA32 bound to the N‐terminus of SMARCAL1 redefines the binding interface between RPA32 and its interacting proteins
  93. Urease inactivation by an unusual GroES chaperonin
  94. Functional disruption of HypB, a GTPase of Helicobacter pylori, by bismuth
  95. In-cell NMR: an emerging approach for monitoring metal-related events in living cells
  96. Size-tunable fabrication of multifunctional Bi2O3 porous nanospheres for photocatalysis, bacteria inactivation and template-synthesis
  97. Nickel translocation between metallochaperones HypA and UreE in Helicobacter pylori
  98. BiOX (X=Cl, Br, I) nanostructures: Mannitol-mediated microwave synthesis, visible light photocatalytic performance, and Cr(VI) removal capacity
  99. Identification of Metal‐Associated Proteins in Cells by Using Continuous‐Flow Gel Electrophoresis and Inductively Coupled Plasma Mass Spectrometry
  100. ChemInform Abstract: Template‐Free Fabrication of Bi2O3 and (BiO)2CO3 Nanotubes and Their Application in Water Treatment.
  101. Tunable BiOCl hierarchical nanostructures for high-efficient photocatalysis under visible light irradiation
  102. Kinetics and thermodynamics of metal binding to the N-terminus of a human copper transporter, hCTR1
  103. Binding of oxo-Cu2 clusters to ferric ion-binding protein A from Neisseria gonorrhoeae: a structural insight
  104. Histidine-rich proteins in prokaryotes: metal homeostasis and environmental habitat-related occurrence
  105. Interaction of SlyD with HypB of Helicobacter pylori facilitates nickel trafficking
  106. Structure-oriented bioinformatic approach exploring histidine-rich clusters in proteins
  107. Iron and bismuth bound human serum transferrin reveals a partially-opened conformation in the N-lobe
  108. Template‐Free Fabrication of Bi2O3 and (BiO)2CO3 Nanotubes and Their Application in Water Treatment
  109. Metallomics in environmental and health related research: Current status and perspectives
  110. Facile Microwave Synthesis of 3D Flowerlike BiOBr Nanostructures and Their Excellent CrVI Removal Capacity
  111. Recent advances in bioinorganic chemistry of bismuth
  112. Folic acid conjugated mPEG-PEI600 as an efficient non-viral vector for targeted nucleic acid delivery
  113. Covalently linking the Escherichia coli global anaerobic regulator FNR in tandem allows it to function as an oxygen stable dimer
  114. Metallo-GTPase HypB from Helicobacter pylori and Its Interaction with Nickel Chaperone Protein HypA
  115. Large-scale synthesis of bismuth hollow nanospheres for highly efficient Cr(vi) removal
  116. Activation of carboplatin and nedaplatin by the N-terminus of human copper transporter 1 (hCTR1)
  117. Comparison between copper and cisplatin transport mediated by human copper transporter 1 (hCTR1)
  118. Probing of bismuth antiulcer drug targets in H. pylori by laser ablation-inductively coupled plasma mass spectrometry
  119. Multifaceted SlyD from Helicobacter pylori: implication in [NiFe] hydrogenase maturation
  120. Microwave synthesis of BiPO4 nanostructures and their morphology-dependent photocatalytic performances
  121. Assembly of Preactivation Complex for Urease Maturation inHelicobacter pylori
  122. Histidine-rich protein Hpn from Helicobacter pylori forms amyloid-like fibrils in vitro and inhibits the proliferation of gastric epithelial AGS cells
  123. Tracking Bismuth Antiulcer Drug Uptake in Single Helicobacter pylori Cells
  124. Metal‐Binding Properties of an Hpn‐Like Histidine‐Rich Protein
  125. The Effect of the Extracellular Domain of Human Copper Transporter (hCTR1) on Cisplatin Activation
  126. The Effect of the Extracellular Domain of Human Copper Transporter (hCTR1) on Cisplatin Activation
  127. NMR Studies of Metalloproteins
  128. Biological Chemistry of Arsenic, Antimony and Bismuth
  129. Biological Chemistry of Antimony and Bismuth
  130. Metalloproteomics of Arsenic, Antimony and Bismuth Based Drugs
  131. Polymeric architectures of bismuth citrate based on dimeric building blocks
  132. Online coupling of reverse-phase and hydrophilic interaction liquid chromatography for protein and glycoprotein characterization
  133. Iron-containing lipoprotein SiaA in SiaABC, the primary heme transporter of Streptococcus pyogenes
  134. Nuclear-based Metallomics in Metal-based Drugs
  135. Bismuth subcarbonate nanoparticles fabricated by water-in-oil microemulsion-assisted hydrothermal process exhibit anti-Helicobacter pylori properties
  136. A new capillary electrophoresis buffer for determining organic and inorganic anions in electroplating bath with surfactant additives
  137. A zinc-binding site by negative selection induces metallodrug susceptibility in an essential chaperonin
  138. A biomimetic zinc activated ion channel
  139. Metallomics: An integrated science for metals in biology and medicine
  140. Metallomics: An integrated biometal science
  141. Reactivity of platinum-based antitumor drugs towards a Met- and His-rich 20mer peptide corresponding to the N-terminal domain of human copper transporter 1
  142. Effect of cyclodextrin dimers with bipyridyl and biphenyl linking groups on carboxyl ester hydrolysis catalyzed by zinc complex
  143. Structure of a Nickel Chaperone, HypA, from Helicobacter pylori Reveals Two Distinct Metal Binding Sites
  144. Iron depletion decreases proliferation and induces apoptosis in a human colonic adenocarcinoma cell line, Caco2
  145. The structural and biological significance of the EAAEAE insert in the α-domain of human neuronal growth inhibitory factor
  146. Crystal Structure and Metal Binding Properties of the Lipoprotein MtsA, Responsible for Iron Transport in Streptococcus pyogenes
  147. Phosphodiester hydrolysis and specific DNA binding and cleavage promoted by guanidinium-functionalized zinc complexes
  148. Important roles of the conserved linker-KKS in human neuronal growth inhibitory factor
  149. Identification and characterization of metallodrug binding proteins by (metallo)proteomics
  150. Editorial and Advisory Board profiles
  151. Identification of Proteins Related to Nickel Homeostasis in Helicobater pylori by Immobilized Metal Affinity Chromatography and Two-Dimensional Gel Electrophoresis
  152. Study on structure–property–reactivity–function relationship of human neuronal growth inhibitory factor (hGIF)
  153. Binding of Ni2+ to a histidine- and glutamine-rich protein, Hpn-like
  154. Structure, topology and assembly of a 32-mer peptide corresponding to the loop 3 and transmembrane domain 4 of divalent metal transporter (DMT1) in membrane-mimetic environments
  155. A Histidine-rich and Cysteine-rich Metal-binding Domain at the C Terminus of Heat Shock Protein A from Helicobacter pylori
  156. Lipoprotein MtsA of MtsABC in Streptococcus pyogenes primarily binds ferrous ion with bicarbonate as a synergistic anion
  157. Double-strand DNA cleavage by copper complexes of 2,2′-dipyridyl with guanidinium/ammonium pendants
  158. The effect of nitric oxide on metal release from metallothionein-3: gradual unfolding of the protein
  159. Biocoordination chemistry of bismuth: Recent advances
  160. Effect of α-domain substitution on the structure, property and function of human neuronal growth inhibitory factor
  161. Bismuth Complexes Inhibit the SARS Coronavirus
  162. Bismuth Complexes Inhibit the SARS Coronavirus
  163. Bioinorganic Chemistry of Bismuth and Antimony: Target Sites of Metallodrugs
  164. A proteomic approach for the identification of bismuth-binding proteins in Helicobacter pylori
  165. Solution structures, dynamics, and lipid‐binding of the sterile α‐motif domain of the deleted in liver cancer 2
  166. Structural prediction of the β-domain of metallothionein-3 by molecular dynamics simulation
  167. Metallodrugs
  168. An Effective Metallohydrolase Model with a Supramolecular Environment: Structures, Properties, and Activities
  169. Bioinorganic Chemistry of Bismuth and Antimony:  Target Sites of Metallodrugs
  170. Silver nanoparticles: partial oxidation and antibacterial activities
  171. Synthesis, Structure, and Activity of Supramolecular Mimics for the Active Site and Arg141 Residue of Copper, Zinc−Superoxide Dismutase
  172. Encapsulation of platinum anticancer drugs by apoferritin
  173. Inhibition of SARS coronavirus helicase by bismuth complexes
  174. Cleavage of double-strand DNA by zinc complexes of dicationic 2,2′-dipyridyl derivatives
  175. Flavonoid Dimers as Bivalent Modulators for Pentamidine and Sodium Stiboglucanate Resistance in Leishmania
  176. Inhibition of urease by bismuth(III): Implications for the mechanism of action of bismuth drugs
  177. Mutation at Glu23 eliminates the neuron growth inhibitory activity of human metallothionein-3
  178. Thermodynamic and Kinetic Aspects of Metal Binding to the Histidine-rich Protein, Hpn
  179. The role of Thr5 in human neuron growth inhibitory factor
  180. Proteomic Analysis of the Mode of Antibacterial Action of Silver Nanoparticles
  181. Solution structure and dynamics of human metallothionein‐3 (MT‐3)
  182. HFIP‐induced structures and assemblies of the peptides from the transmembrane domain 4 of membrane protein Nramp1
  183. Fabrication of bismuth subcarbonate nanotube arrays from bismuth citrate
  184. Expression and characterization of a histidine-rich protein, Hpn: potential for Ni 2+ storage in Helicobacter pylori
  185. Complexation of antimony (SbV) with guanosine 5′-monophosphate and guanosine 5′-diphospho-d-mannose: Formation of both mono- and bis-adducts
  186. An Insight of S-Nitrosylation of Human GIF
  187. The Stepwise Process of Chromium-Induced DNA Breakage:  Characterization by Electrochemistry, Atomic Force Microscopy, and DNA Electrophoresis
  188. Transferrin-Mediated Gold Nanoparticle Cellular Uptake
  189. 51 Sb Antimony in Medicine
  190. NMR structures and orientation of the fourth transmembrane domain of the rat divalent metal transporter (DMT1) with G185D mutation in SDS micelles
  191. Structure, Assembly, and Topology of the G185R Mutant of the Fourth Transmembrane Domain of Divalent Metal Transporter
  192. Controlled synthesis of high crystalline bismuth sulfide nanorods: using bismuth citrate as a precursor
  193. In Vitro Inhibition of Human Immunodeficiency Virus Type‐1 (HIV‐1) Reverse Transcriptase by Gold(III) Porphyrins
  194. Dynamic and Kinetic Aspects of Metallodrugs by NMR
  195. The low pKa value of iron‐binding ligand Tyr188 and its implication in iron release and anion binding of human transferrin
  196. Inhibition of alcohol dehydrogenase by bismuth☆
  197. Structure and topology of the transmembrane domain 4 of the divalent metal transporter in membrane‐mimetic environments
  198. Bismuth in Medicine
  199. DNA hydrolysis promoted by di- and multi-nuclear metal complexes
  200. The effect of the EAAEAE insert on the property of human metallothionein-3
  201. Structure of Colloidal Bismuth Subcitrate (CBS) in Dilute HCl:  Unique Assembly of Bismuth Citrate Dinuclear Units ([Bi(cit)2Bi]2-)
  202. Recognition of antimony and bismuth by peptides and proteins: insight into the mechanism of action
  203. Three dimensional structures and topology of the transmembrane domain 4 of divalent metal transporter (DMT1) in membrane-mimetic environments
  204. Reduction of pentavalent antimony by trypanothione and formation of a binary and ternary complex of antimony(III) and trypanothione
  205. Membrane-inserted conformation of transmembrane domain 4 of divalent-metal transporter
  206. Binding of bismuth to serum proteins: implication for targets of Bi(III) in blood plasma
  207. Gold(iii) porphyrins as a new class of anticancer drugs: cytotoxicity, DNA binding and induction of apoptosis in human cervix epitheloid cancer cellsElectronic supplementary information (ESI) available: Further experimental and crystallographic details...
  208. An oscillating C22? unit inside a copper rectangleElectronic supplementary information (ESI) available: NMR spectra and computational details. See http://www.rsc.org/suppdata/cc/b3/b301842c/
  209. Helicases as antiviral drug targets
  210. Rapid reduction of pentavalent antimony by trypanothione: potential relevance to antimonial activationElectronic supplementary information (ESI) available: experimental details. See http://www.rsc.org/suppdata/cc/b2/b210240d/
  211. Complexation of ytterbium to human transferrin and its uptake by K562 cells
  212. Targeted Drug Delivery via the Transferrin Receptor-Mediated Endocytosis Pathway
  213. Stereo- and Enantioselective Alkene Epoxidations: A Comparative Study of D4- and D2-Symmetric Homochiral trans-Dioxoruthenium(VI) Porphyrins
  214. The role of the transferrin–transferrin-receptor system in drug delivery and targeting
  215. Interactions of Bismuth with Human Lactoferrin and Recognition of the BiIII−Lactoferrin Complex by Intestinal Cells
  216. Competitive Binding of Bismuth to Transferrin and Albumin in Aqueous Solution and in Blood Plasma
  217. Intracellular Sb-trypanothione
  218. Complexation of Antimony(III) by Trypanothione
  219. Interaction of antimony tartrate with the tripeptide glutathione
  220. TiIV Uptake and Release by Human Serum Transferrin and Recognition of TiIV-Transferrin by Cancer Cells:  Understanding the Mechanism of Action of the Anticancer Drug Titanocene Dichloride
  221. Stereoselective Formation of Seven-Coordinate Titanium(IV) Monomer and Dimer Complexes of Ethylenebis(o-hydroxyphenyl)glycine
  222. ChemInform Abstract: Transferrin as a Metal Ion Mediator
  223. Interactions of Bismuth Complexes with Metallothionein(II)
  224. Transferrin as a Metal Ion Mediator
  225. Coordination chemistry of metals in medicine: target sites for bismuth
  226. Bismuth Antiulcer Complexes
  227. N-lobe versus C-lobe complexation of bismuth by human transferrin
  228. Coordination of Zn2+ (and Cd2+) by Prokaryotic Metallothionein
  229. The First Specific TiIV-Protein Complex: Potential Relevance to Anticancer Activity of Titanocenes
  230. [1H,13C] NMR determination of the order of lobe loading of human transferrin with iron: comparison with other metal ions
  231. New approach to the solution chemistry of bismuth citrate antiulcer complexes
  232. The Biological and Medicinal Chemistry of Bismuth
  233. Determination of Bismuth in Serum Urine by Direct Injection Nebulization Inductively Coupled Plasma Mass Spectrometry
  234. Rationalisation of metal binding to transferrin: Prediction of metal-protein stability constants
  235. Rationalization of the Strength of Metal Binding to Human Serum Transferrin
  236. Molecular assemblies of diazafluorenone Schiff-base amphiphiles. III.13C NMR investigations of reversed micelles in deuteriochloroform
  237. Bismuth(III) Complexes of the Tripeptide Glutathione (γ‐L‐Glu–L‐Cys–Gly)
  238. Solid-state carbon-13 nuclear magnetic resonance investigations of bismuth citrate complexes and crystal structure of Na2[Bi2(cit)2]·7H2O
  239. 1H NMR Studies of the Imidazole Complex of Cytochrome c: Resonance Assignment and Structural Characterization of the Heme Cavity
  240. Ranitidine bismuth(III) citrate
  241. NMR Investigation of the Aggregation Behavior of Diazafluorenone Schiff Base Amphiphile in CDCL3Solution
  242. Assignments of Nonexchangeable Proton Resonances and the Solution Structures of d–TGGGT
  243. Syntheses and Characterization of Coenzyme B12 Analogues Containing 2′-Deoxynucleosede
  244. Two Dimensional1HNMR Studies on 2′5′-Dideoxyadenosylcobalamin